By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Perspectives > Explainers > The EU Nutrient Reference Value (NRV): What 1,000% on a Label Really Means
ExplainersHealth Policy

The EU Nutrient Reference Value (NRV): What 1,000% on a Label Really Means

GMJ
Last updated: 20/08/2026 05:30
By
GMJ Perspectives Desk
Share
6 Min Read
EU supplement labels declare vitamins as percentages of the Nutrient Reference Value
SHARE
3 min read|699 words

Pick up any European vitamin D3 product delivering 50 µg and the label declares, entirely lawfully, 1,000% NRV. To many readers that reads like a ten-fold overdose; to others, like a promise of ten-fold benefit. Both readings misunderstand what the reference value is — and since every EU supplement label is built on this system under Regulation (EU) No 1169/2011, decoding it correctly is basic label literacy.

Contents
  • What the NRV actually is
  • Why supplements exceed 100% on purpose
  • The number that actually guards safety: the UL
  • Why some ingredients show no NRV at all
  • Reading a real label, start to finish
  • The clinical bottom line
  • Primary sources

What the NRV actually is

The Nutrient Reference Value is a single, population-wide labelling reference for each essential vitamin and mineral, fixed in Annex XIII of Regulation 1169/2011: vitamin D 5 µg, vitamin E 12 mg, vitamin C 80 mg, and so on. Its ancestry is the recommended-daily-allowance tradition: an intake sufficient to prevent classical deficiency in nearly all healthy people. Three design features explain everything confusing about it. It is one number for everyone — the same 5 µg of vitamin D applies to a 20-year-old lifeguard in Crete and an 80-year-old in a Baltic care home, because labels cannot be personalised. It is deficiency-anchored, not optimisation-anchored — the question it answers is “how little prevents disease,” not “how much is ideal.” And it is frozen for comparability — values change rarely, by regulation, so that percentages mean the same thing across products and years.

Why supplements exceed 100% on purpose

Once the NRV’s question is clear, high percentages stop being paradoxical. A supplement exists precisely for people whose sun exposure, diet, age or physiology leave them below adequacy — and for several nutrients the doses used in the clinical literature sit well above deficiency-prevention minimums. Vitamin D illustrates it perfectly: the 5 µg NRV predates modern status research, while mainstream clinical practice corrects deficiency with 25–100 µg/day — hence products at 500–2,000% NRV that remain squarely within safety limits. The percentage is not a danger gauge; it is a comparison to a deliberately conservative historical baseline.

The number that actually guards safety: the UL

Safety lives in a different figure entirely: the Tolerable Upper Intake Level (UL), set by EFSA per nutrient as the highest chronic daily intake unlikely to pose risk to almost anyone. Put the two side by side and the label percentages re-scale instantly: vitamin D — NRV 5 µg, UL 100 µg, so a “1,000% NRV” (50 µg) product sits at half the safety ceiling; vitamin E — NRV 12 mg, UL 300 mg, so a 134 mg dose reading “1,117% NRV” is at ~45% of the UL. Reading NRV% without knowing the UL is like judging speed by comparing to walking pace: technically a comparison, practically uninformative. The literate question for any product is not “how many % NRV?” but “what fraction of the EFSA UL does the daily dose represent?”

Submit Your Paper
GMJ_Submit_Banner

Why some ingredients show no NRV at all

Omega-3, astaxanthin and CoQ10 labels carry no percentage — a legal fact with a biological reason. NRVs exist only for essential vitamins and minerals with defined deficiency diseases. EPA/DHA have EFSA-recommended intakes and authorised claims but no NRV slot; astaxanthin is a beneficial non-essential carotenoid; CoQ10 is endogenously synthesised. “No NRV” therefore signals category, not obscurity: dosing for these substances is anchored in clinical-trial ranges and, where applicable, EFSA claim conditions — 250 mg/day EPA+DHA being the canonical example — rather than in deficiency arithmetic.

Reading a real label, start to finish

The competent sequence: identify the daily dose the maker recommends; read absolute amounts (µg/mg) per that dose, not per capsule if they differ; treat NRV% as a rough “contribution to basic needs” indicator; check the dose against the EFSA UL for genuine safety context; and for no-NRV substances, check the dose against the studied clinical range instead. Sixty seconds, four numbers, no alarm and no magical thinking — which is what a labelling system is for.

The clinical bottom line

NRV is a deficiency-prevention yardstick standardised for labels, not a target and not a limit. Percentages above 100 are intentional design for a corrective product category; real safety context comes from EFSA’s Upper Intake Levels, against which typical quality formulations — including 1,000% NRV vitamin D3 — sit with comfortable margin. Learn the two-number habit (NRV for contribution, UL for ceiling) and supplement labels become arithmetic instead of advertising.

Primary sources

  • Regulation (EU) No 1169/2011 on food information to consumers — Annex XIII (NRVs)
  • EFSA: Dietary Reference Values and Tolerable Upper Intake Levels
  • EFSA: UL for vitamin D (100 µg/day adults)
  • GMJ: What EFSA health claims actually mean

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026Aug 20, 2026
The 25-Hydroxyvitamin D Test: What to Ask For and How to Read Your ResultAug 20, 2026
CoQ10 and Statins: What Patients on Cholesterol Medication Should KnowAug 20, 2026
Why Marine Microalgae? The Original Source of Omega-3 and AstaxanthinAug 20, 2026
Explore more on this topic:🧭 Leukaemia hub🧭 African Trypanosomiasis (Sleeping Sickness) hub
🔥 Most read this week
1High-Dose Zinc Supplements May Create Copper Deficiency, Warn Nutrition Experts
2How Coffee Brewing Method Affects Cholesterol: The Science Behind Diterpenes and Filters
3How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained
4Why High-Dose Vitamin B12 Supplements Work Despite Poor Absorption
Related reference
  • Astaxanthin · Ingredient
  • Vitamin D · Ingredient
  • Vitamin C · Ingredient
  • Vitamin A · Ingredient
  • Vitamin E · Ingredient
  • SAMe · Ingredient
PG
Editorial oversight
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
📬 GMJ Health Digest
Evidence-based medical news, once a week. Free, no spam, unsubscribe anytime.
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Perspectives Desk
Follow:
GMJ Perspectives Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026

Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the…

The 25-Hydroxyvitamin D Test: What to Ask For and How to Read Your Result

One blood test defines vitamin D status — if you order the…

CoQ10 and Statins: What Patients on Cholesterol Medication Should Know

Statins save lives — and, as a documented side effect of how…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

NIAID headquarters building representing federal infectious disease research leadershipIllustrative image · Immunohistochemistry technologies with AI.png by MykhailoPervak / CC BY 4.0 via Wikimedia Commons (CC BY 4.0)
Health PolicyPolicy & Systems

Acting NIAID Chief Steps Down as Lab Safety Concerns Mount

By
GMJ Policy Desk
07/07/2026
Healthcare professional using digital tablet to access public health resources on government platform
Health PolicyPolicy & Systems

UK Launches Comprehensive Digital Public Health Resource Hub for Healthcare Professionals

By
GMJ Policy Desk
24/05/2026
Microscopic image of chromoblastomycosis showing characteristic sclerotic bodies in skin tissueIllustrative image · National Lab Week 130410-F-TT327-015.jpg by Airman 1st Class Jason Couillard / Public domain via Wikimedia Commons (Public domain)
Clinical UpdatesExplainersPerspectivesPractice

Chromoblastomycosis: A Neglected Tropical Infection Resurfacing in Clinical Practice

By
GMJ Practice Desk
12/07/2026
NHS hospital building with protest signs about patient advocacy
Health PolicyPolicy & Systems

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

By
GMJ Policy Desk
09/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?